Prescription drug · NDA
Folotyn (Pralatrexate) NDC 72893-003
Pralatrexate 20 mg/mL · Injection · Intravenous · Acrotech Biopharma Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72893-003-01 | 7289300030172893000301 | 1 VIAL in 1 CARTON (72893-003-01) / 1 mL in 1 VIALMarketed from Sep 24, 2009 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Folotyn
- Generic name (nonproprietary)
- pralatrexate
- Active ingredients
- Pralatrexate — 20 mg/mL
- Dosage form
- Injection
- Route
- Intravenous
- Labeler
- Acrotech Biopharma IncNDC labeler code 72893
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 022468
- Marketing start
- Listing expires
- Identifiers
- Product ID 72893-003_a10f6330-f643-4d2b-b4b0-541d5e8ec387SPL ID a10f6330-f643-4d2b-b4b0-541d5e8ec387
- Pharmacologic class
- Folate Analog Metabolic Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N472893000301followed by a unit qualifier and the quantityPackage 72893-0003-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 72893-003
- What is NDC 72893-003?
- 72893-003 is the product NDC for Folotyn (pralatrexate), Pralatrexate 20 mg/mL injection, listed with the FDA by Acrotech Biopharma Inc. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Folotyn (Pralatrexate).
- What is the active ingredient?
- Pralatrexate.
- Who is the labeler?
- Acrotech Biopharma Inc, NDC labeler code 72893. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Folotyn?
- 1 other product NDC are listed under this name. See all Folotyn NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Folotyn products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Folotynpralatrexate | Pralatrexate 40 mg/2mL | InjectionIntravenous | Acrotech Biopharma Inc | 72893-005 | 72893-0005-01 |
Other NDCs under NDA 022468
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Folotynpralatrexate | Pralatrexate 40 mg/2mL | InjectionIntravenous | Acrotech Biopharma Inc | 72893-005 |
| Pralatrexate | Pralatrexate 20 mg/mL | InjectionIntravenous | Fresenius Kabi USA, LLC | 65219-550 |
| Pralatrexate | Pralatrexate 40 mg/2mL | InjectionIntravenous | Fresenius Kabi USA, LLC | 65219-552 |